Four tools, four different jobs. This page lays out where each one wins — including the cases where Vistoxx is the wrong choice and you should pick something else.
Pricing and features verified from each provider's public pages in August 2026. Plans change — check the linked source before you subscribe.
These products only look similar from a distance. Each is genuinely better than the others at something specific.
AI analysis grounded in company filings, an AI portfolio review, a weekly macro & micro briefing that ties economic events to the sectors they move, sector rotation, and read-only broker sync — at the lowest monthly price of the four.
Free · Pro ₹250/mo · ₹2,500/yr
Ten years of financials, a custom ratio query language, concall notes and Excel automation. The most generous free tier for fundamental research.
Free · ₹4,999/yr
Stocks, ETFs, mutual funds and US equities in one place, with multi-demat linking, price forecasts and a polished native mobile app.
Free · ₹399/mo · ₹2,999/yr
Thousands of screener parameters, strategy backtesting, DVM scores, analyst forecasts and superstar-investor portfolios.
Free · GuruQ ₹310/mo · ₹2,190/yr
Rows where Vistoxx loses are included on purpose. A table where one column wins everything is marketing, not a comparison.
| Capability | Vistoxx ₹250/mo | Screener.in ₹4,999/yr | Tickertape ₹399/mo | Trendlyne ₹310/mo |
|---|---|---|---|---|
| Free plan | ✓ | ✓ | ✓ | ✓ |
| Lowest paid tier | ₹2,500/yr | ₹4,999/yr | ₹2,999/yr | ₹2,190/yr |
| AI analysis grounded in filings | ✓ | ✓ Screener AI (document insights) | ✕ | ✕ |
| AI chat assistant | ✓ Zippy | ✕ | ✕ | ✕ |
| AI portfolio review | ✓ | ✕ | ✕ | ✓ Portfolio reports |
| Weekly macro → sector AI briefing | ✓ Market + per stock | — | — | — |
| Portfolio tracking | ✓ | ✕ | ✓ | ✓ |
| Broker sync | ✓ Zerodha, Angel One (read-only) | ✕ | ✓ Multi-demat linking | ✕ |
| Sector rotation analysis | ✓ | ✕ | ✕ | ✕ |
| Stock screener | ✓ Screener + Minervini | ✓ Custom ratio queries | ✓ 60+ filters | ✓ 1,758–3,512 parameters |
| 10-year financial history | ✕ | ✓ | ~ Partial coverage | ~ Partial coverage |
| Strategy backtesting | ✕ | ✕ | ✕ | ✓ |
| Analyst forecasts | ✕ | ✕ | ✓ Price & EPS forecasts | ✓ Forecaster |
| Mutual funds & ETFs | ✕ | ✕ | ✓ | ✓ |
| US equities | ✕ | ✕ | ✓ | ✓ On Pro plans |
| Native mobile app | ✕ | ✕ | ✓ | ✓ |
| Excel / data export | ✕ | ✓ | ✓ | ✓ |
Sources: Screener.in pricing · Tickertape pricing · Trendlyne plans · Vistoxx pricing
Screener.in is the reference tool for fundamental research in India, and its free tier is genuinely hard to beat — ten years of financial data, custom ratios, stock screens and Excel automation cost nothing. Its paid Active Investor plan at ₹4,999/year adds Screener AI for document insights, detailed peer comparison, segment results and unlimited concall notes.
The gap is workflow. Screener.in gives you the data and expects you to do the analysis; it has no portfolio tracking and no broker integration. Vistoxx starts from the opposite end — it reads filings and announcements for you, produces a written analysis with a verdict, syncs your actual holdings from Zerodha or Angel One, and reviews the portfolio as a whole. It also adds a layer neither tool's financials reach: a weekly macro & micro briefing that connects the week's economic events — rates, crude, freight, tariffs, the monsoon — to the sectors and companies they actually move.
Pick Screener.in if you build your own screens, want a decade of financials, and prefer to read statements yourself. Pick Vistoxx if you want the reading done for you and your portfolio tracked in the same place. They overlap less than they appear to — plenty of investors run both.
Tickertape is the broadest of the four by asset class. Stocks, ETFs, mutual funds and US equities all live in one app, you can link multiple demat accounts, and it ships a polished native mobile experience. Paid plans run ₹399/month or ₹2,999/year and add 60+ screening filters, price and EPS forecasts, data export and an ad-free experience.
Vistoxx is narrower on purpose: Indian exchange-listed equities only, no mutual funds, no US stocks, no native app. What it adds instead is depth of analysis on that narrower surface — four AI analysis engines working from filings, a conversational assistant, sector rotation, and a Minervini-style technical screener.
Pick Tickertape if your money sits across mutual funds, ETFs and US stocks, or a mobile app is non-negotiable. Pick Vistoxx if you're an Indian-equity investor who wants deeper AI research on the stocks you actually hold.
Trendlyne is the power user's screener. GuruQ at ₹310/month exposes 1,758 screener parameters, 30 watchlists and 200 annual backtests; StratQ at ₹5,900/year roughly doubles that to 3,512 parameters and 1,200 backtests. Add DVM scores, the Forecaster analyst-estimate product and superstar-investor portfolios, and no one else on this list matches its screening surface area.
Vistoxx does not compete on parameter count and has no backtesting at all. Its screener is deliberately simpler, with a Minervini template for trend-following setups. The differentiation is again AI-first analysis, broker-synced portfolio review and sector rotation, at a lower entry price.
Pick Trendlyne if you screen actively, backtest strategies, or want analyst forecast data. Pick Vistoxx if screening is a smaller part of your process than understanding and monitoring what you own.
If any of these describe you, one of the other three will serve you better and we'd rather you find that out here than after paying.
Vistoxx covers BSE/NSE-listed equities only. Tickertape handles all of these in one place; Trendlyne's Pro plans add US coverage.
Vistoxx has no backtesting engine. Trendlyne includes 200–1,200 annual backtests depending on plan.
Screener.in's ten-year data and custom ratio query language are the deepest here — and free.
Vistoxx is responsive web only. Tickertape and Trendlyne both ship native apps.
Not entirely. Screener.in is stronger for deep fundamental research — ten years of financial history, custom ratio queries, Excel export. Vistoxx is stronger when you want AI to read filings and produce an analysis, plus portfolio tracking and broker sync, which Screener.in doesn't offer. Many investors use both.
It is a weekly AI briefing on the economic events that actually moved the Indian market — a rate decision, a crude move, a freight or tariff shock, the monsoon — and, for each one, which sectors and industries it helps or hurts and by what mechanism. The same briefing is available per stock, narrowed to that company’s industry and what the event means for that specific business. It is deliberately a short briefing, not a dashboard of indicators. All four tools give you market data and news; the difference is that this reads the events and tells you where they land. Pro only.
As of August 2026, Vistoxx Pro at ₹250/month or ₹2,500/year is the lowest monthly paid tier of the four. Trendlyne GuruQ is ₹310/month or ₹2,190/year, Tickertape is ₹399/month or ₹2,999/year, and Screener.in Active Investor is ₹4,999/year. Note that Trendlyne's annual GuruQ price undercuts Vistoxx's annual price.
Yes — read-only sync with Zerodha (Kite Connect) and Angel One (SmartAPI), so your holdings populate automatically. Vistoxx never places trades. Screener.in and Trendlyne don't offer broker sync; Tickertape supports linking demat accounts.
No. Vistoxx covers Indian exchange-listed equities on BSE and NSE only. If you need mutual funds, ETFs or US equities in the same tool, Tickertape or Trendlyne's global plans fit better.
Not currently. Vistoxx is a responsive web app that works in a mobile browser, but there's no native iOS or Android app. Tickertape and Trendlyne both ship native apps.
The free plan needs no card. Sync a broker or add holdings manually, and see what the AI analysis actually says about stocks you own.